1. Malhotra M, Tomaro-Duchesneau C, Saha S and Prakash S (2014). Intranasal delivery of chitosan-siRNA nanoparticle formulation to the brain; Drug delivery systems. Methods in Molecular Biology.1141, 233-47.
  2. Malhotra M, Tomaro-Duchesneau C, Saha S and Prakash S (2013). Intranasal siRNA delivery to the brain by TAT/MGF tagged PEGylated chitosan nanoparticles. Journal of Pharmaceutics. 2013, Article ID: 812387, 10 pages.
  3. Malhotra M, Tomaro-Duchesneau C, Saha S and Prakash S (2013). Systemic siRNA delivery via peptide tagged polymeric nanoparticles, targeting PLK1 gene in a mouse xenograft model of colorectal cancer. International Journal of Biomaterials. 2013, Article ID: 252531, 13 pages.
  4. Malhotra M, Tomaro-Duchesneau C, Saha S, Kahouli I and Prakash S (2013). Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA. International Journal of Nanomedicine. 2013, 8:2041-2052.
  5. Malhotra M, Tomaro-Duchesneau C and Prakash S (2013). Synthesis of TAT peptide tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases. Biomaterials 34, 1270-1280.
  6. Malhotra M, Lane C, Tomaro-Duchesneau C, Saha and Prakash S (2011). A novel scheme for synthesis of PEG-grafted-chitosan polymer for preparation of nanoparticles and other applications. International Journal of Nanomedicine. Vol. 2011, 6: 485-494.
  7. Malhotra M, Nambiar S, Swamy VR and Prakash S (2011). siRNA design strategies for effective targeting and gene silencing. Expert Opinion on Drug Discovery. Vol. 6, 3: 269-289.
  8. Malhotra M and Prakash S (2011). Targeted Drug Delivery Across Blood-Brain-Barrier Using Cell Penetrating Peptides Tagged Nanoparticles. Current Nanosciences. Vol. 7, 1: 81-93.
  9. Prakash S, Malhotra M, Swamy VR (2010) Non-viral siRNA delivery and gene silencing for neurodegenerative diseases; RNA interference from laboratory to clinical application. Methods in Molecular Biology 623, 211-229.
  10. Malhotra M, Kulamarva A, Sebak S, Paul A, Bhathena J, Mirzaei M and Prakash S (2009). Ultra-small nanoparticles of low molecular weight Chitosan as an efficient delivery system targeting neuronal cells. Drug Development and Industrial Pharmacy. Vol. 35, 6:719-726.
  11. Prakash S and Malhotra M (2008). Recent advancements in targeted delivery of therapeutic molecules in neurodegenerative disease – spinocerebellar ataxia – opportunities and challenges. Drug Target Insights. 3, 99-117.